BUDIMEX A ZY 5/ PLBUDMX00013 /
17/06/2024 11:26:41 | Diferencia -9.500 | Volumen | Bid11:57:01 | Ask11:57:01 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
150.700EUR | -5.93% | - Volumen de negocios: - |
149.800Volumen de oferta: 350 | 158.000Tamaño/ Volumen/ Formato de Ask: 350 | 3.96 mil millonesEUR | - | - |
GlobeNewswire
12:04
Gilat to Acquire Stellar Blu, an IFC Market Leader with a First-to-Market ESA-Based Solution for Com...
GlobeNewswire
12:00
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c...
GlobeNewswire
12:00
Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual ...
GlobeNewswire
12:00
Scott McGillivray Real Estate Trust II Joins addy Platform, Pioneering a New Era of Accessible Real ...
GlobeNewswire
12:00
Wawa’s Hoagiefest® is Back with $5 Shortis and $6 Classics and Four Additional Weeks of Savings! “Ke...
GlobeNewswire
12:00
Atomo Coffee Reveals Breakthrough Discovery to Instantly Slash Coffee-Related Deforestation, Urging ...
GlobeNewswire
12:00
Shoals Technologies Group to Launch Global Suite of Solutions at Intersolar Europe
GlobeNewswire
11:39
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancem...
GlobeNewswire
11:23
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groun...
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página